{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:55:08Z","timestamp":1793962508646,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T00:00:00Z","timestamp":1432252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T00:00:00Z","timestamp":1432252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Osteopontin (OPN) is a phosphoglycoprotein with important roles in tissue homeostasis, wound healing, immune regulation, and stress responses. It is expressed constitutively in the brain and upregulated during neuroinflammatory responses; for example, after focal cerebral ischemia. To date, its effects on neural stem cells (NSC) remain to be elucidated and are, accordingly, the subject of this study.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Method<\/jats:title>\n                        <jats:p>Primary fetal rat NSC were cultured as homogenous monolayers and treated with different concentrations of OPN. Fundamental properties of NSC were assessed following OPN exposure, including proliferative activity, survival under oxidative stress, migration, and differentiation potential. To elucidate a putative action of OPN via the CXC chemokine receptor type 4 (CXCR4), the latter was blocked with AMD3100. To investigate effects of OPN on endogenous NSC in vivo, recombinant OPN was injected into the brain of healthy adult rats as well as rats subjected to focal cerebral ischemia. Effects of OPN on NSC proliferation and neurogenesis in the subventricular zone were studied immunohistochemically.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>OPN dose-dependently increased the number of NSC in vitro. As hypothesized, this effect was mediated through CXCR4. The increase in NSC number was due to both enhanced cell proliferation and increased survival, and was confirmed in vivo. Additionally, OPN dose-dependently stimulated the migration of NSC via CXCR4. Moreover, in the presence of OPN, differentiation of NSC led to a significant increase in neurogenesis both in vitro as well as in vivo after cerebral ischemia.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Data show positive effects of OPN on survival, proliferation, migration, and neuronal differentiation of NSC. At least in part these effects were mediated via CXCR4. Results suggest that OPN is a promising substance for the targeted activation of NSC in future experimental therapies for neurological disorders such as stroke.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13287-015-0098-x","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T15:31:10Z","timestamp":1432222270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4"],"prefix":"10.1186","volume":"6","author":[{"given":"Monika","family":"Rabenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Hucklenbroich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Willuweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ladwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gereon Rudolf","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Josef","family":"Langen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adele","family":"Rueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,22]]},"reference":[{"key":"98_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1440-1827.2011.02649.x","volume":"61","author":"T Uede","year":"2011","unstructured":"Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int. 2011;61:265\u201380.","journal-title":"Pathol Int"},{"key":"98_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/03008208909002412","volume":"23","author":"WT Butler","year":"1989","unstructured":"Butler WT. The nature and significance of osteopontin. Connect Tissue Res. 1989;23:123\u201336.","journal-title":"Connect Tissue Res"},{"key":"98_CR3","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1096\/fasebj.7.15.8262332","volume":"7","author":"DT Denhardt","year":"1993","unstructured":"Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J. 1993;7:1475\u201382.","journal-title":"FASEB J"},{"key":"98_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1749-6632.1995.tb44624.x","volume":"760","author":"CM Giachelli","year":"1995","unstructured":"Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M. Osteopontin expression in cardiovascular diseases. Ann N Y Acad Sci. 1995;760:109\u201326.","journal-title":"Ann N Y Acad Sci"},{"key":"98_CR5","doi-asserted-by":"crossref","first-page":"18696","DOI":"10.1016\/S0021-9258(17)44808-3","volume":"265","author":"K Singh","year":"1990","unstructured":"Singh K, DeVouge MW, Mukherjee BB. Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J Biol Chem. 1990;265:18696\u2013701.","journal-title":"J Biol Chem"},{"key":"98_CR6","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1161\/01.ATV.16.11.1365","volume":"16","author":"X Wang","year":"1996","unstructured":"Wang X, Louden C, Ohlstein EH, Stadel JM, Gu JL, Yue TL. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty. Arterioscler Thromb Vasc Biol. 1996;16:1365\u201372.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"98_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cytogfr.2008.08.001","volume":"19","author":"KX Wang","year":"2008","unstructured":"Wang KX, Denhardt DT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 2008;19:333\u201345.","journal-title":"Cytokine Growth Factor Rev"},{"key":"98_CR8","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1172\/JCI12980","volume":"107","author":"DT Denhardt","year":"2001","unstructured":"Denhardt DT, Noda M, O\u2019Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest. 2001;107:1055\u201361.","journal-title":"J Clin Invest"},{"key":"98_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2478\/s13380-012-0028-7","volume":"3","author":"A Brown","year":"2012","unstructured":"Brown A. Osteopontin: a key link between immunity, inflammation and the central nervous system. Transl Neurosci. 2012;3:288\u201393.","journal-title":"Transl Neurosci"},{"key":"98_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0021-9258(17)42407-0","volume":"269","author":"SM Hwang","year":"1994","unstructured":"Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, et al. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem. 1994;269:711\u20135.","journal-title":"J Biol Chem"},{"key":"98_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1126\/science.287.5454.860","volume":"287","author":"S Ashkar","year":"2000","unstructured":"Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000;287:860\u20134.","journal-title":"Science"},{"key":"98_CR12","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.1062960","volume":"294","author":"D Chabas","year":"2001","unstructured":"Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 2001;294:1731\u20135.","journal-title":"Science"},{"key":"98_CR13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4049\/jimmunol.166.2.1079","volume":"166","author":"H Guo","year":"2001","unstructured":"Guo H, Cai CQ, Schroeder RA, Kuo PC. Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol. 2001;166:1079\u201386.","journal-title":"J Immunol"},{"key":"98_CR14","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1161\/01.STR.29.8.1698","volume":"29","author":"JA Ellison","year":"1998","unstructured":"Ellison JA, Velier JJ, Spera P, Jonak ZL, Wang X, Barone FC, et al. Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke. Stroke. 1998;29:1698\u2013706. discussion 1707.","journal-title":"Stroke"},{"key":"98_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1415","volume":"8","author":"EM Hur","year":"2007","unstructured":"Hur EM, Youssef S, Haws ME, Zhang SY, Sobel RA, Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol. 2007;8:74\u201383.","journal-title":"Nat Immunol"},{"key":"98_CR16","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/01.WCB.0000141559.17620.36","volume":"24","author":"M Hedtj\u00e4rn","year":"2004","unstructured":"Hedtj\u00e4rn M, Mallard C, Hagberg H. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab. 2004;24:1333\u201351.","journal-title":"J Cereb Blood Flow Metab"},{"key":"98_CR17","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1523\/JNEUROSCI.18-06-02075.1998","volume":"18","author":"X Wang","year":"1998","unstructured":"Wang X, Louden C, Yue TL, Ellison JA, Barone FC, Solleveld HA, et al. Delayed expression of osteopontin after focal stroke in the rat. J Neurosci. 1998;18:2075\u201383.","journal-title":"J Neurosci"},{"key":"98_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/jcbfm.2008.17","volume":"28","author":"KP Doyle","year":"2008","unstructured":"Doyle KP, Yang T, Lessov NS, Ciesielski TM, Stevens SL, Simon RP, et al. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. J Cereb Blood Flow Metab. 2008;28:1235\u201348.","journal-title":"J Cereb Blood Flow Metab"},{"key":"98_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/sj.jcbfm.9600022","volume":"25","author":"R Meller","year":"2005","unstructured":"Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H, et al. Neuroprotection by osteopontin in stroke. J Cereb Blood Flow Metab. 2005;25:217\u201325.","journal-title":"J Cereb Blood Flow Metab"},{"key":"98_CR20","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1093\/brain\/awl094","volume":"129","author":"M Schroeter","year":"2006","unstructured":"Schroeter M, Zickler P, Denhardt DT, Hartung HP, Jander S. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain. 2006;129:1426\u201337.","journal-title":"Brain"},{"key":"98_CR21","doi-asserted-by":"crossref","first-page":"7768","DOI":"10.1523\/JNEUROSCI.18-19-07768.1998","volume":"18","author":"J Liu","year":"1998","unstructured":"Liu J, Solway K, Messing RO, Sharp FR. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci. 1998;18:7768\u201378.","journal-title":"J Neurosci"},{"key":"98_CR22","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1523\/JNEUROSCI.6092-09.2010","volume":"30","author":"MA Rueger","year":"2010","unstructured":"Rueger MA, Backes H, Walberer M, Neumaier B, Ullrich R, Simard ML, et al. Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. J Neurosci. 2010;30:6454\u201360.","journal-title":"J Neurosci"},{"key":"98_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0092-8674(02)00862-0","volume":"110","author":"H Nakatomi","year":"2002","unstructured":"Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell. 2002;110:429\u201341.","journal-title":"Cell"},{"key":"98_CR24","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1161\/STROKEAHA.108.533141","volume":"40","author":"M Chopp","year":"2009","unstructured":"Chopp M, Li Y, Zhang ZG. Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke. 2009;40:S143\u20135.","journal-title":"Stroke"},{"key":"98_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nm747","volume":"8","author":"A Arvidsson","year":"2002","unstructured":"Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med. 2002;8:963\u201370.","journal-title":"Nat Med"},{"key":"98_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nn.3706","volume":"17","author":"HB Huttner","year":"2014","unstructured":"Huttner HB, Bergmann O, Salehpour M, R\u00e1cz A, Tatarishvili J, Lindgren E, et al. The age and genomic integrity of neurons after cortical stroke in humans. Nat Neurosci. 2014;17:801\u20133.","journal-title":"Nat Neurosci"},{"key":"98_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nature04940","volume":"442","author":"A Androutsellis-Theotokis","year":"2006","unstructured":"Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW, et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature. 2006;442:823\u20136.","journal-title":"Nature"},{"key":"98_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/01.STR.0000252156.65953.a9","volume":"38","author":"RR Leker","year":"2007","unstructured":"Leker RR, Soldner F, Velasco I, Gavin DK, Androutsellis-Theotokis A, McKay RD. Long-lasting regeneration after ischemia in the cerebral cortex. Stroke. 2007;38:153\u201361.","journal-title":"Stroke"},{"key":"98_CR29","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.2174\/1381612811319360010","volume":"19","author":"MA Rueger","year":"2013","unstructured":"Rueger MA, Androutsellis-Theotokis A. Identifying endogenous neural stem cells in the adult brain in vitro and in vivo: novel approaches. Curr Pharm Des. 2013;19:6499\u2013506.","journal-title":"Curr Pharm Des"},{"key":"98_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12015-014-9512-5","volume":"10","author":"R Klein","year":"2014","unstructured":"Klein R, Blaschke S, Neumaier B, Endepols H, Graf R, Keuters M, et al. The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo. Stem Cell Rev. 2014;10:539\u201347.","journal-title":"Stem Cell Rev"},{"key":"98_CR31","doi-asserted-by":"crossref","unstructured":"Hucklenbroich J, Klein R, Neumaier B, Graf R, Fink GR, Schroeter M, et al. Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo. Stem Cell Res Ther. 2014; doi:10.1186\/scrt500.","DOI":"10.1186\/scrt500"},{"key":"98_CR32","first-page":"353","volume":"152","author":"CM Giachelli","year":"1998","unstructured":"Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol. 1998;152:353\u20138.","journal-title":"Am J Pathol"},{"key":"98_CR33","first-page":"393","volume":"19","author":"JM Kim","year":"2007","unstructured":"Kim JM, Min SK, Kim H, Kang HK, Jung SY, Lee SH, et al. Vacuolar-type H+\u2212ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration. Int J Mol Med. 2007;19:393\u2013400.","journal-title":"Int J Mol Med"},{"key":"98_CR34","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.bbrc.2007.12.076","volume":"366","author":"LF Raheja","year":"2008","unstructured":"Raheja LF, Genetos DC, Yellowley CE. Hypoxic osteocytes recruit human MSCs through an OPN\/CD44-mediated pathway. Biochem Biophys Res Commun. 2008;366:1061\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"98_CR35","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1182\/blood-2004-11-4422","volume":"106","author":"SK Nilsson","year":"2005","unstructured":"Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood. 2005;106:1232\u20139.","journal-title":"Blood"},{"key":"98_CR36","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/trf.12102","volume":"53","author":"YC Tanhehco","year":"2013","unstructured":"Tanhehco YC, Vogl DT, Stadtmauer EA, O\u2019Doherty U. The evolving role of plerixafor in hematopoietic progenitor cell mobilization. Transfusion. 2013;53:2314\u201326.","journal-title":"Transfusion"},{"key":"98_CR37","doi-asserted-by":"publisher","first-page":"18117","DOI":"10.1073\/pnas.0408258102","volume":"101","author":"J Imitola","year":"2004","unstructured":"Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha\/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A. 2004;101:18117\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"98_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023831","volume":"6","author":"R Zhang","year":"2011","unstructured":"Zhang R, Pan X, Huang Z, Weber GF, Zhang G. Osteopontin enhances the expression and activity of MMP-2 via the SDF-1\/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One. 2011;6, e23831.","journal-title":"PLoS One"},{"key":"98_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ijdevneu.2012.04.003","volume":"30","author":"HS Kalluri","year":"2012","unstructured":"Kalluri HS, Dempsey RJ. Osteopontin increases the proliferation of neural progenitor cells. Int J Dev Neurosci. 2012;30:359\u201362.","journal-title":"Int J Dev Neurosci"},{"key":"98_CR40","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.neuint.2009.08.007","volume":"55","author":"YP Yan","year":"2009","unstructured":"Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochem Int. 2009;55:826\u201332.","journal-title":"Neurochem Int"},{"key":"98_CR41","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/j.1471-4159.2009.06059.x","volume":"109","author":"YP Yan","year":"2009","unstructured":"Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Persistent migration of neuroblasts from the subventricular zone to the injured striatum mediated by osteopontin following intracerebral hemorrhage. J Neurochem. 2009;109:1624\u201335.","journal-title":"J Neurochem"},{"key":"98_CR42","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1128\/MCB.20.8.2734-2742.2000","volume":"20","author":"YH Lin","year":"2000","unstructured":"Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, Yen JJ, et al. Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol Cell Biol. 2000;20:2734\u201342.","journal-title":"Mol Cell Biol"},{"key":"98_CR43","first-page":"206","volume":"12","author":"K Kawamura","year":"2005","unstructured":"Kawamura K, Iyonaga K, Ichiyasu H, Nagano J, Suga M, Sasaki Y. Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin Diagn Lab Immunol. 2005;12:206\u201312.","journal-title":"Clin Diagn Lab Immunol"},{"key":"98_CR44","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1158\/0008-5472.CAN-06-3625","volume":"67","author":"JL Lee","year":"2007","unstructured":"Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, Chen JY. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer Res. 2007;67:2089\u201397.","journal-title":"Cancer Res"},{"key":"98_CR45","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/1541-7786.MCR-10-0472","volume":"9","author":"X Luo","year":"2011","unstructured":"Luo X, Ruhland MK, Pazolli E, Lind AC, Stewart SA. Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway. Mol Cancer Res. 2011;9:1018\u201329.","journal-title":"Mol Cancer Res"},{"key":"98_CR46","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1158\/0008-5472.CAN-08-2970","volume":"69","author":"E Pazolli","year":"2009","unstructured":"Pazolli E, Luo X, Brehm S, Carbery K, Chung JJ, Prior JL, et al. Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res. 2009;69:1230\u20139.","journal-title":"Cancer Res"},{"key":"98_CR47","first-page":"41","volume":"25","author":"M Matsuura","year":"2011","unstructured":"Matsuura M, Suzuki T, Suzuki M, Tanaka R, Ito E, Saito T. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma. Oncol Rep. 2011;25:41\u20137.","journal-title":"Oncol Rep"},{"key":"98_CR48","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1074\/jbc.M706712200","volume":"283","author":"JA Kang","year":"2008","unstructured":"Kang JA, Zhou Y, Weis TL, Liu H, Ulaszek J, Satgurunathan N, et al. Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. J Biol Chem. 2008;283:6997\u20137006.","journal-title":"J Biol Chem"},{"key":"98_CR49","first-page":"181","volume":"86","author":"KA Sailor","year":"2003","unstructured":"Sailor KA, Dhodda VK, Rao VL, Dempsey RJ. Osteopontin infusion into normal adult rat brain fails to increase cell proliferation in dentate gyrus and subventricular zone. Acta Neurochir Suppl. 2003;86:181\u20135.","journal-title":"Acta Neurochir Suppl"},{"key":"98_CR50","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1161\/STROKEAHA.110.608315","volume":"42","author":"CT van Velthoven","year":"2011","unstructured":"van Velthoven CT, Heijnen CJ, van Bel F, Kavelaars A. Osteopontin enhances endogenous repair after neonatal hypoxic-ischemic brain injury. Stroke. 2011;42:2294\u2013301.","journal-title":"Stroke"},{"key":"98_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12013-012-9449-8","volume":"65","author":"C Zou","year":"2013","unstructured":"Zou C, Luo Q, Qin J, Shi Y, Yang L, Ju B, et al. Osteopontin promotes mesenchymal stem cell migration and lessens cell stiffness via integrin \u03b21, FAK, and ERK pathways. Cell Biochem Biophys. 2013;65:455\u201362.","journal-title":"Cell Biochem Biophys"},{"key":"98_CR52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/leu.2011.197","volume":"26","author":"MP Rettig","year":"2012","unstructured":"Rettig MP, Ansstas G, DiPersio JF. Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4. Leukemia. 2012;26:34\u201353.","journal-title":"Leukemia"},{"key":"98_CR53","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4049\/jimmunol.182.1.604","volume":"182","author":"JM Petty","year":"2009","unstructured":"Petty JM, Lenox CC, Weiss DJ, Poynter ME, Suratt BT. Crosstalk between CXCR4\/stromal derived factor-1 and VLA-4\/VCAM-1 pathways regulates neutrophil retention in the bone marrow. J Immunol. 2009;182:604\u201312.","journal-title":"J Immunol"},{"key":"98_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1139\/o04-106","volume":"83","author":"K Miura","year":"2005","unstructured":"Miura K, Uniyal S, Leabu M, Oravecz T, Chakrabarti S, Morris VL, et al. Chemokine receptor CXCR4-beta1 integrin axis mediates tumorigenesis of osteosarcoma HOS cells. Biochem Cell Biol. 2005;83:36\u201348.","journal-title":"Biochem Cell Biol"},{"key":"98_CR55","first-page":"6751","volume":"63","author":"AR Cardones","year":"2003","unstructured":"Cardones AR, Murakami T, Hwang ST. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res. 2003;63:6751\u20137.","journal-title":"Cancer Res"},{"key":"98_CR56","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11481-014-9521-9","volume":"9","author":"G Banisadr","year":"2014","unstructured":"Banisadr G, Schwartz SR, Podojil JR, Piccinini LA, Lanker S, Miller SD, et al. Integrin\/chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol. 2014;9:438\u201345.","journal-title":"J Neuroimmune Pharmacol"},{"key":"98_CR57","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/WNR.0b013e328355380e","volume":"23","author":"S Plantman","year":"2012","unstructured":"Plantman S. Osteopontin is upregulated after mechanical brain injury and stimulates neurite growth from hippocampal neurons through \u03b21 integrin and CD44. Neuroreport. 2012;23:647\u201352.","journal-title":"Neuroreport"},{"key":"98_CR58","doi-asserted-by":"publisher","first-page":"13632","DOI":"10.1073\/pnas.2234031100","volume":"100","author":"CT Ekdahl","year":"2003","unstructured":"Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A. 2003;100:13632\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"98_CR59","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1088417","volume":"302","author":"ML Monje","year":"2003","unstructured":"Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003;302:1760\u20135.","journal-title":"Science"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-015-0098-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0098-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:27:16Z","timestamp":1728923236000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-015-0098-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1186\/s13287-015-0098-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,22]]},"assertion":[{"value":"30 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"99"}}